Just read the article you posted. The interesting part to me is the comment about providing better access to meds which I assume means more affordable. This is where I think the attack in ariad loses some steam. If the patient has insurance I'm not sure that the price increase really impacts them and thus doesn't impact their access. If the patient doesn't have insurance and are able to access the drug through ariad's patient assistance program the price increase would also not impact access. Is my thinking flawed here. Looking for others tempered views.
News 
Market Data 
Discover 
